273: Back to school for biotech, Biogen's potential pivot, & Illumina's next chapter
The Readout Loud
00:00
FDA Advisory Panel Meeting for CRISPR-based Treatment for Sickle Cell Disease
This chapter discusses the upcoming FDA advisory panel meeting for a potentially curative, CRISPR-based medicine for sickle cell disease. The hosts anticipate that the treatment has a good chance of approval and reflect on the role of the FDA in regulating gene therapy.
Transcript
Play full episode
